MIRIKIZUMAB THERAPY IS ASSOCIATED WITH IMPROVED FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Miguel Regueiro  1     Mingyang Shan  2     Paul Pollack  2     Lai Shan Chan  2     Pieter Hindryckx  3     Theresa Hunter Gibble  2     Monika Fischer  4     David T. Rubin     Deanilee Deckard    
1 Cleveland Clinic Main Campus,Cleveland,United States
2 Eli Lilly and Company,Indianapolis,United States
3 Hospital of Ghent,Ghent,Belgium
4 Indiana University,Indianapolis,United States

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing